| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 323 | 1,895 | 2,713 | 2,172 | | Cost of Revenue | 305 | 1,043 | 1,095 | 1,000 | | | Gross Profit | 18 | 852 | 1,617 | 1,171 | | | Operating Expenses | | Research Development | 873 | 882 | 1,105 | 933 | | Selling General and Administrative | 1,660 | 2,035 | 1,583 | 1,562 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 29 | 338 | 339 | 335 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,545) | (2,402) | (1,409) | (1,659) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | (4) | 28 | 39 | | Earnings Before Interest And Taxes | (2,544) | (2,406) | (1,381) | (1,620) | | Interest Expense | 41 | 32 | 50 | 50 | | Income Before Tax | (2,585) | (2,438) | (1,431) | (1,671) | | Income Tax Expense |
-
| 18 | 37 | (29) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,585) | (2,456) | (1,468) | (1,642) | | | Non-recurring Events | | Discontinued Operations | (1,306) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,544) | (2,456) | (1,468) | (1,642) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,544) | ($2,456) | ($1,468) | ($1,642) |
|
0.11% Nasdaq 
0.01%
Income Statement
